Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Berwick

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
British Journal of Pharmacology|May 29, 2021
The development of inhibitors of leucine-rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of playSonia Azeggagh, Daniel C Berwick
Human Molecular Genetics|August 18, 2012
LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6Daniel C Berwick, Kirsten Harvey
Journal of Molecular Cell Biology|October 12, 2013
The regulation and deregulation of Wnt signaling by PARK genes in health and diseaseDaniel C Berwick, Kirsten Harvey
Trends in Cell Biology|February 11, 2011
LRRK2 signaling pathways: the key to unlocking neurodegeneration?Daniel C Berwick, Kirsten Harvey
Frontiers in Cellular Neuroscience|June 12, 2013
LRRK2: an éminence grise of Wnt-mediated neurogenesis?Daniel C Berwick, Kirsten Harvey
Biochemical Society Transactions|September 20, 2012
The importance of Wnt signalling for neurodegeneration in Parkinson's diseaseDaniel C Berwick, Kirsten Harvey
Biochemical Society Transactions|December 4, 2016
L'RRK de Triomphe: a solution for LRRK2 GTPase activity?Jonathon Nixon-Abell, Daniel C Berwick, Kirsten Harvey
Molecular Neurodegeneration|December 23, 2019
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the sameDaniel C Berwick, George R Heaton, Sonia Azeggagh, et al.
Brain Research|January 13, 2009
Regulation of Brn-3a N-terminal transcriptional activity by MEK1/2-ERK1/2 signalling in neural differentiationDaniel C Berwick, Mattia Calissano, Jacqueline D Corness, et al.
The Journal of Biological Chemistry|July 11, 2002
The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytesDaniel C Berwick, Ingeborg Hers, Kate J Heesom, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
British Journal of Pharmacology|May 29, 2021
The development of inhibitors of leucine-rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of playSonia Azeggagh, Daniel C Berwick
Human Molecular Genetics|August 18, 2012
LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6Daniel C Berwick, Kirsten Harvey
Journal of Molecular Cell Biology|October 12, 2013
The regulation and deregulation of Wnt signaling by PARK genes in health and diseaseDaniel C Berwick, Kirsten Harvey
Trends in Cell Biology|February 11, 2011
LRRK2 signaling pathways: the key to unlocking neurodegeneration?Daniel C Berwick, Kirsten Harvey
Frontiers in Cellular Neuroscience|June 12, 2013
LRRK2: an éminence grise of Wnt-mediated neurogenesis?Daniel C Berwick, Kirsten Harvey
Biochemical Society Transactions|September 20, 2012
The importance of Wnt signalling for neurodegeneration in Parkinson's diseaseDaniel C Berwick, Kirsten Harvey
Biochemical Society Transactions|December 4, 2016
L'RRK de Triomphe: a solution for LRRK2 GTPase activity?Jonathon Nixon-Abell, Daniel C Berwick, Kirsten Harvey
Molecular Neurodegeneration|December 23, 2019
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the sameDaniel C Berwick, George R Heaton, Sonia Azeggagh, et al.
Brain Research|January 13, 2009
Regulation of Brn-3a N-terminal transcriptional activity by MEK1/2-ERK1/2 signalling in neural differentiationDaniel C Berwick, Mattia Calissano, Jacqueline D Corness, et al.
The Journal of Biological Chemistry|July 11, 2002
The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytesDaniel C Berwick, Ingeborg Hers, Kate J Heesom, et al.
Pageof 2